SCHEMBL6984124

SCHEMBL6984124

CC[Si](CC)(CC)O[C@@H]1C(=O)N(C(=O)c2ccccc2)[C@@H]1C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 3/20 0.39
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
POLB P06746 1/20 0.38
TPSAB1 Q15661 1/20 0.38
TPSD1 Q9BZJ3 1/20 0.38
TPSG1 Q9NRR2 1/20 0.38
GAA P10253 1/20 0.36
ELANE P08246 3/20 0.36
SIRT3 Q9NTG7 1/20 0.36
RIPK1 Q13546 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
HIF1A Q16665 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
LMNA P02545 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984120 1.00 FOLH1 (0.39) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6984115 1.00 FOLH1 (0.39) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6977780 0.85 KMT2A (0.43) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6977783 0.85 KMT2A (0.43) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6977776 0.85 KMT2A (0.43) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL4366611 0.82 ELANE (0.49) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL5887457 0.82 ELANE (0.49) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL5887453 0.82 ELANE (0.49) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6332781 0.81 FOLH1 (0.39) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6332778 0.81 FOLH1 (0.39) FOLH1KMT2AMEN1POLBTPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187061-A1 Antitumor agnets; antileukemia agents FLORIDA STATE UNIVERSITY 2003-10-02 US disclosed
EP-0667772-B1 TAXANES HAVING AN ALKYL SUBSTITUTED SIDE-CHAIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM UNIV FLORIDA STATE (US) 2003-05-14 EP disclosed
US-6521660-B2 Anticancer, antitumor agents FLORIDA STATE UNIVERSITY 2003-02-18 US disclosed
US-20020147335-A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them FLORIDA STATE UNIVERSITY 2002-10-10 US disclosed
US-6335362-B1 ANTITUMOR AND ANTICARCINOGENIC AGENTS FOR LEUKEMIA FLORIDA STATE UNIVERSITY 2002-01-01 US disclosed
EP-1146043-A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them FLORIDA STATE UNIVERSITY (US) 2001-10-17 EP disclosed
WO-1994010997-A1 TAXANES HAVING AN ALKYL SUBSTITUTED SIDE-CHAIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FLORIDA STATE UNIVERSITY (US) 1994-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187061-A1 Antitumor agnets; antileukemia agents MCL1, TP53, EWSR1 FOLH1 3240/4885KMT2A 574/4885MEN1 959/4885
US-20020147335-A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them TOP2A, TOP2B, TUBB3 FOLH1 1121/4885KMT2A 2652/4885MEN1 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.